Sectors & IndustriesConsumer DefensivePharmaceutical Retailers

Best Pharmaceutical Retailer Stocks to Buy Now (2026)

Top pharmaceutical retailer stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best pharmaceutical retailer stocks to buy now. Learn More.

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 2 best drug store stocks to buy right now are:

High Tide (NASDAQ:HITI) is the #1 top pharmaceutical retailer stock out of 8 with a Zen Rating of B. Stocks with a rating of B have had an average return of +17.17% per year. Learn more.

The Component Grade breakdown for High Tide (NASDAQ:HITI) is: Value: C, Growth: A, Momentum: C, Sentiment: A, Safety: D, Financials: C, and AI: B.

High Tide (NASDAQ:HITI) has a Due Diligence Score of 24, which is 7 points higher than the pharmaceutical retailer industry average of 17.

HITI passed 8 out of 33 due diligence checks and has weak fundamentals. High Tide has seen its stock lose -25.29% over the past year, overperforming other pharmaceutical retailer stocks by 71 percentage points.

Datameds Ai (NASDAQ:MEDS) is the #2 top pharmaceutical retailer stock out of 8 with a Zen Rating of F. Stocks with a rating of F have had an average return of -12.86% per year. Learn more.

The Component Grade breakdown for Datameds Ai (NASDAQ:MEDS) is: Value: F, Growth: C, Momentum: D, Sentiment: C, Safety: D, Financials: F, and AI: F.

Datameds Ai (NASDAQ:MEDS) has a Due Diligence Score of 6, which is -11 points lower than the pharmaceutical retailer industry average of 17.

MEDS passed 2 out of 33 due diligence checks and has weak fundamentals. Datameds Ai has seen its stock lose -89.71% over the past year, overperforming other pharmaceutical retailer stocks by 7 percentage points.

100% of pharmaceutical retailer stocks rated by analysts are a strong sell right now. On average, analysts expect pharmaceutical retailer stocks to rise by 18.64% over the next year.

0% of pharmaceutical retailer stocks have a Zen Rating of A (Strong Buy), 50% of pharmaceutical retailer stocks are rated B (Buy), 0% are rated C (Hold), 0% are rated D (Sell), and 50% are rated F (Strong Sell).

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 2 most undervalued pharmaceutical retailer stocks right now are:

High Tide (NASDAQ:HITI) is the most undervalued pharmaceutical retailer stock based on its Valuation Rating of C. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

High Tide has a valuation score of 43, which is 31 points higher than the pharmaceutical retailer industry average of 12. It passed 3 out of 7 valuation due diligence checks.

High Tide's stock has dropped -25.29% in the past year. It has overperformed other stocks in the pharmaceutical retailer industry by 71 percentage points.

Datameds Ai (NASDAQ:MEDS) is the second most undervalued pharmaceutical retailer stock based on its Valuation Rating of F. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Datameds Ai has a valuation score of 0, which is -12 points higher than the pharmaceutical retailer industry average of 12. It passed 0 out of 7 valuation due diligence checks.

Datameds Ai's stock has dropped -89.71% in the past year. It has overperformed other stocks in the pharmaceutical retailer industry by 7 percentage points.

Pharmaceutical retailer stocks were down -2.03% in the last day, and down -7.74% over the last week.

We couldn't find a catalyst for why pharmaceutical retailer stocks are down.